Compass Therapeutics said its cancer treatment improved progression-free survival in a recent trial, but didn't meet its secondary endpoint in overall survival. Shares fell 23% to $3.85 in premarket ...

Bile duct cancer, or cholangiocarcinoma, is a serious concern due to its rapid progression and often mild, easily mistaken ...

The international group of experts, including Professor John Bridgewater (UCL Cancer Institute), is calling for rapid improvements in diagnosis, treatment and research for cholangiocarcinoma, also ...

Compass Therapeutics Inc. CMPX shares are tumbling on Monday as the company announced results from its COMPANION-002 study, ...

Survival rates for people with cholangiocarcinoma, a silent but deadly form of cancer originating in the bile ducts, are dismal and a new approach is needed, argues a panel of leading experts ...

Bile duct cancer is classified by location: intrahepatic, perihilar, or distal, influencing symptoms and treatment options. Diagnosis involves blood tests, imaging, endoscopic procedures, and biopsy ...

Patients with a rare form of bile duct cancer could soon benefit from a new treatment option after the National Institute for Health and Care Excellence (NICE) recommended zanidatamab for NHS use in ...

Integrating Pathologic Stage and Perioperative Circulating Tumor Cell Variations: Early Relapse Prediction Model for Resectable Non–Small Cell Lung Cancer The CAPTURE assay isolated exfoliated tumor ...

Every single type of cancer, explained A cancer diagnosis can be both terrifying and confusing for those afflicted, as well as for friends and family who don’t really know what the diagnosis means. It ...

A trial drug, which is prescribed when surgery is no longer an option, gave Huw precious time to see Idris turn one.